6 November 2014: promotion of unlicensed medicines
Updated 31 March 2015
© Crown copyright 2015
This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit nationalarchives.gov.uk/doc/open-government-licence/version/3 or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: psi@nationalarchives.gov.uk.
Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned.
This publication is available at https://www.gov.uk/government/publications/advertising-investigations-november-2014/6-november-2014-promotion-of-unlicensed-medicines
Jenson Pharmaceuticals complained about a letter and price list for unlicensed medicines containing vitamin D, which was sent by Sterling Pharmaceuticals to clinicians and practice managers in March 2014.
The complainant was concerned that the advert included product claims and encouraged readers to prescribe which therefore amounted to the promotion of unlicensed medicines.
MHRA upheld the complaint. Sterling agreed to withdraw the material and ensure that future price lists are limited to a simple listing of the product details.